tRNA-derived fragments: Key determinants of cancer metastasis with emerging therapeutic and diagnostic potentials

Mohammad Salehi1, Mohammad Javad Kamali2, Aliakbar Rajabzadeh3

  • 1Department of Medical Genetics, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran; Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.

Insights

Small non-coding RNAs called tRNA-derived fragments (tRFs) are key drivers of cancer metastasis. Targeting these tRFs offers promising new strategies for anti-metastasis therapies and diagnostics.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Metastasis is a major cause of cancer mortality and treatment failure.
  • The molecular mechanisms underlying metastasis are not fully understood.
  • tRNA-derived fragments (tRFs) are emerging as critical regulators of tumor progression.

Purpose of the Study:

  • To review the biogenesis and functions of tRFs.
  • To elucidate the role of tRFs in promoting cancer metastasis.
  • To explore the potential of tRFs as therapeutic and diagnostic targets for metastasis.

Main Methods:

  • Literature review of studies on tRFs and cancer metastasis.
  • Analysis of tRF production from tRNA modifications.
  • Examination of tRFs' regulatory roles in post-transcriptional and translational processes.

Main Results:

  • tRFs are generated from tRNA cleavage and exhibit diverse functions.
  • Tumor cells exploit tRFs to facilitate metastatic development and survival.
  • tRFs influence gene expression through microRNA-like activity and RNA-binding protein displacement.
  • tRFs regulate translation initiation, ribosome synthesis, and epigenetic modifications.

Conclusions:

  • tRFs are crucial mediators of cancer metastasis.
  • Aberrant tRF expression contributes to the metastatic tumor microenvironment.
  • tRFs represent promising biomarkers and therapeutic targets for combating cancer metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K